Blood samples from DR- and DS-TB patients were obtained before receiving the anti-TB therapy and then after 2 and 6 months of therapy to confirm if Mtb strains (DR and DS) or anti-TB treatment induced an altered expression of the TNF pathway molecules. The gene discussed is TNF; the disease is tuberculosis.